University Hospitals Seidman Cancer Center Brings New Hope for Patients with Mesothelioma
If you or a loved one has been diagnosed with mesothelioma, we understand the anxiety you must feel, and we can help. Mesothelioma is estimated to affect about 3,000 people in the U.S. in 2015. This type of cancer is rare and has been on the decrease over the past few decades.
UH Seidman Cancer Center is a nationally recognized cancer program with expertise in both routine and complex care for every stage of mesothelioma, from the earliest lesions to the most challenging cases. Our entire multidisciplinary team evaluates and reviews every case so diagnosis and treatment decisions are based on the knowledge of our team of experts. Together, we work through every step of cancer care, offering innovative cancer treatment that brings new hope to patients.
Our team practices with advanced treatments, including:
Highest Standard of Excellence
Because of our high standard of excellence in research and clinical care, the National Cancer Institute (NCI) has recognized Case Comprehensive Cancer Center, which includes UH Seidman Cancer Center, as one of only 41 Comprehensive Cancer Centers in the country. We put the patient at the center of a compassionate, multidisciplinary team. Members of this team include:
- Genetic counselors
- Medical geneticists
- Medical oncologists
- Nurse navigators
- Nurse practitioners
- Radiation oncologists
- Social workers
Disease-Specific Tumor Board Review
Our multidisciplinary team of highly skilled cancer experts performs a disease-specific tumor board review each week. Every patient at UH Seidman Cancer Center benefits from the resources of an entire team of national experts to guide mesothelioma treatment decisions. The close relationships between world-class researchers and medical clinicians ensure that the latest research findings are translated into new, effective cancer treatments as quickly as possible.
Cancer Clinical Trials
UH Seidman Cancer Center has many available clinical trials for patients with cancer, including:
- Studying safe dose and side effects of a cancer drug for solid tumors that have spread or grown. Learn more.